⏳ Fetching live dividend data...
Home › Calculator › IBIO Dividend Calculator 2026
iBio, Inc. · NASDAQ
Price: $1.70 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in IBIO → $3788790338953.48M in 10 years · $315,470,662,949,729,340.00/month
iBio, Inc., a United States-based biotechnology firm, delivers contract development and manufacturing (CDMO) services to its collaborators and external clients. Its operations are structured into two distinct segments: Biopharmaceuticals and Bioprocessing. The company's leading therapeutic candidate, IBIO-100, is currently progressing through investigational new drug (IND) development, aimed at addressing systemic scleroderma and idiopathic pulmonary fibrosis. Additionally, iBio is engaged in the preclinical development of vaccine candidates, including IBIO-200 and IBIO-201, designed to prevent severe acute respiratory syndrome coronavirus 2. Another candidate, IBIO-400, is in development for the treatment of classical swine fever. Beyond its proprietary pipeline, iBio provides recombinant proteins to third parties, available both as catalog items and custom-synthesized products. It also offers comprehensive services spanning process development, advanced manufacturing, filling and finishing, and bioanalytical support. iBio maintains several strategic partnerships: a licensing agreement with Planet Biotechnology, Inc. for infectious disease therapeutics; a collaborative effort with The Texas A&M University System focused on COVID-19 vaccine candidates; a licensing pact with the University of Natural Resources and Life Sciences, Vienna; and a collaboration with CC-Pharming Ltd. Its corporate headquarters are situated in Bryan, Texas.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open IBIO position with:
Real after-tax yield depends on where you live and how you hold IBIO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 117.65% | 114.85% | $11,765 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 100.00% | 97.20% | $10,000 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 94.12% | 91.32% | $9,412 / yr |
| 🇬🇧 UK ISA | 0% | 117.65% | 114.85% | $11,765 / yr |
| 🇬🇧 UK Taxable | 8.75% | 107.36% | 104.56% | $10,736 / yr |
| 🇨🇦 TFSA | 0% | 117.65% | 114.85% | $11,765 / yr |
| 🇨🇦 CA Taxable | 25% | 88.24% | 85.44% | $8,824 / yr |
| 🇦🇺 Super (pension) | 15% | 100.00% | 97.20% | $10,000 / yr |
| 🇦🇺 AU Taxable | 30% | 82.36% | 79.56% | $8,236 / yr |
| 🇩🇪 DE Taxable | 26.375% | 86.62% | 83.82% | $8,662 / yr |
| 🇫🇷 FR Taxable | 30% | 82.36% | 79.56% | $8,236 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
IBIO pays quarterly — 4 times per year. Next ex-div: TBD.
How IBIO compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for IBIO sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-05-18 | 60,000 | $1.42 | $85.2K | ||
| Buy | 2026-03-26 | 1,434 | $1.76 | $2.5K | ||
| Buy | 2026-03-26 | 12,500 | $1.64 | $20.5K | ||
| Buy | 2026-03-19 | 24,835 | $2.02 | $50.1K | ||
| Buy | 2026-03-19 | 12,336 | $2.02 | $24.9K | ||
| A-Award | 2026-01-28 | 146,000 | $2.23 | $325.6K | ||
| A-Award | 2026-01-28 | 179,000 | $2.23 | $399.2K | ||
| A-Award | 2026-01-28 | 479,000 | $2.23 | $1.07M | ||
| A-Award | 2025-11-20 | 13,500 | $1.00 | $13.5K | ||
| A-Award | 2025-11-20 | 13,500 | $1.00 | $13.5K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Insiders are net buyers — historically a positive signal for dividend sustainability. Last purchase: 2026-03-26
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the IBIO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →